The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

What is the Experience of the Professional Nurse Advocates (PNAs) Application of the A-EQUIP Model Into Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06170879
Recruitment Status : Recruiting
First Posted : December 14, 2023
Last Update Posted : December 21, 2023
Sponsor:
Information provided by (Responsible Party):
University Hospitals of North Midlands NHS Trust

Brief Summary:
The study will utilise focus groups with trained PNAs from different Trusts spread over the Midlands region within England. This approach will help explore the experiences and views of trained PNAs in the application of the role and the foundations on which it is supported. It will also supply valuable feedback regarding the preparation, implementation, and outcome of adopting the PNA position with health care organisations, as there is a suggestion that the role could expand from England to the United Kingdom and possibly the United States of America.

Condition or disease
Staff Attitude Professional Role

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Other
Time Perspective: Other
Official Title: What is the Experience of the Professional Nurse Advocates (PNAs) Application of the A-EQUIP Model Into Practice
Actual Study Start Date : September 21, 2023
Estimated Primary Completion Date : June 30, 2024
Estimated Study Completion Date : June 30, 2024



Primary Outcome Measures :
  1. To measure the experiences of PNAs in implementing the role within their clinical practice and using the A-EQUIP model [ Time Frame: 3 months ]
    To explore the experiences of Professional Nurse Advocates and their application of the A-EQUIP model into clinical practice



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Professional nurse advocates working in the Midlands
Criteria

Inclusion Criteria:

• Qualified Professional Nurse Advocate (PNAs) all of whom would have successfully completed a PNA level 7 module provided by a Higher Education Institution within England

Exclusion Criteria:

• Any qualified nurse who has not successfully completed a PNA module.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06170879


Locations
Layout table for location information
United Kingdom
University Hospitals of North Midlands NHS Trust Recruiting
Stoke-on-Trent, United Kingdom
Contact: Megan Young    01782675384    megan.young@uhnm.nhs.uk   
Principal Investigator: Karen Griffiths         
Sponsors and Collaborators
University Hospitals of North Midlands NHS Trust
Layout table for additonal information
Responsible Party: University Hospitals of North Midlands NHS Trust
ClinicalTrials.gov Identifier: NCT06170879    
Other Study ID Numbers: LPR 3286
First Posted: December 14, 2023    Key Record Dates
Last Update Posted: December 21, 2023
Last Verified: May 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No